Cargando…
Elabela is a reliable biomarker for predicting early onset preeclampsia: A comparative study
BACKGROUND: Preeclampsia (PE) is a multisystemic metabolic disease with an undetermined etiology. PE is a worldwide cause of maternal and perinatal morbidity, subdivided into early (EoPE) and late-onset (LoPE) according to 34 wk of gestation as a divider. Many researchers investigated biomarkers for...
Autores principales: | Amer Ali, Eham, Nori, Wassan, Salman, Alea Farhan, Al-Rawi, Taghreed S Saeed, Hameed, Ban H, Al-Ani, Raid M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303616/ https://www.ncbi.nlm.nih.gov/pubmed/37388778 http://dx.doi.org/10.12998/wjcc.v11.i17.3993 |
Ejemplares similares
-
Fertility outcomes following bariatric surgery
por: Nori, Wassan, et al.
Publicado: (2023) -
Update on hydroxychloroquine use in pregnancy
por: Nori, Wassan, et al.
Publicado: (2023) -
Predicting late‐onset preeclampsia by detecting ELABELA content using an immunochromatographic colloidal gold test strip: Blood ELABELA content predicts the risk of pre‐eclampsia
por: Yang, Na, et al.
Publicado: (2023) -
Can Fetal Heart Lie? Intrapartum CTG Changes in COVID-19 Mothers
por: Farhan, Fatin Shallal, et al.
Publicado: (2022) -
Vaginal microbes confounders and implications on women's health
por: Nori, Wassan, et al.
Publicado: (2023)